Member Info for taffsensation

Missing that went through at 13.08:11

Just check out thisismoney.co.uk

The delay in reporting that acacia is now more than likely out is disgraceful and bordering on illegal. Hey what's the point of having regulations they are just for show. That will also be having an effect on SP

If the PALoH trial is successful, (6 months trial) it could be rolled out across the NHS within a year, under National Institute for Health and Care Excellence (Nice) guidance. There is also interest in the bedside test from Australia, the USA, Israel and the Netherlands.

That would be a very nice order from the NHS initially and will snowball into further revenues.

Buy price drops and you can't buy. Order being filled. My 1st ever post on this share but I have been watching it intently for weeks.

why would the MM take tons of sells then lose money by moving it down? Common sense missing there.

This is also very interesting selling Microgen part of the group of companies

https://www.meslo.com/category/650/Bacteria-Testing.html

Moving freely at the minute

responding to HawkesBay. Talking nonsense doesn't become factual if your are relentless with the same drivel.

I think people are not understanding the reality of the situation and that goes for all 'testing' oriented stocks. It is not going to take '1' test and then off you go you're fine, people will have to have regular tests initially weekly then fortnightly then monthly until this dreaded virus is under control. So I've all the gloom and doom about Roche et al saying Govt has ordered 10m. Population is 68m then multiply that by the number of tests that will be needed per individual. The number of tests needed for the Uk alone will be far in excess of 300m at the very least.

Admission date is key for this employee 29th May 2020 just in time for news ;-)

Think the clue is in 'FOOL' LMAO

Covid god knows why my computer spells clvid!!! Agghh!

Yep it's everyone over the age of 5 with symptoms can have a Clvid test. I wonder whose test they'll use.......ummm

Seems they do a lot more than most know have a look.

https://www.genesig.com/products

Well public knowledge is sales to 100 countries, Exisg free, mobile covid testing, clvid surface testing etc. so none of this would be considered 'inside knowledge' and that as far as I am aware can all be RNs'd as a net result. Normally Directors buy to falsely inflate a company's position - not the case here, or to raise funds as they can't get funds anywhere else - not the case here, or to make a quick profit before the business folds - not the case here.

Despite the rise the SP and valuation is nowhere near where it should be yet. Nice to see but still has a lot of catching up to do. Just add Exisg free, mobile Covid-19 testing, surface testing, additional contracts and then think about what the SP should be. Graham is one sort cookie indeed.

Well look at that the best ever purchase they will ever make :-)

This is taken from simplywallst
https://simplywall.st/stocks/gb/pharmaceuticals-biotech/aim-ncyt/novacyt-shares#ownership

58.38% Eiffel Investment Group S.A.S. 39,505,227 €134.3m 0% 59.34%
9.83% ABN AMRO Group N.V., Asset Management Arm 6,651,288 €22.6m 0% 11.94%
3.72%. Legal & General Investment Management Limited 2,515,909 €8.6m 0% 0.01%
2.16. Talence Gestion SAS 1,461,313 €5.0m 0% 17.32%
1.88%. Harbert Management Corporation 1,270,624 €4.3m 0% 100%
0.16% Andbank Wealth Management SGIIC S.A.U. 109,909 €373.7k 0% 0.13%
0.15%. Lyxor International Asset Management S.A. 99,132 €337.0k 0% no data
0.077%. Graham Mullis 52,138 €177.3k 0% no data
0.025%. James Wakefield 16,839 €57.3k 0% no data
0.025%. Anthony Dyer 16,839 €57.3k 0% no data
0.025%. Andrew John Heath 16,839 €57.3k 0% no data
0.025%. Edwin Snape 16,839 €57.3k 0% no data
0.023%. Jean-Pierre Crinelli 15,233 €51.8k 0% no data

Covid mobile testing as announced in RNS might come in rather handy ;-)

I admire you for continuing to try and flog a dead horse.